Taken together, these data not only suggested that FLOT1 can be used as a marker to identify subsets of HCC patients with more aggressive disease, but also indicated that FLOT1 might play an important role in the progression and invasion of HCC. Here, FLOT1 is linked to hepatocellular carcinoma.